Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL5231687 | 0.95 | — | — | |
| Sulfuric Acid SCHEMBL6197568 | 0.95 | — | — | |
| Sulfuric Acid SCHEMBL27967364 | 0.95 | — | — | |
| Methylene Chloride SCHEMBL9185705 | 0.86 | — | — | |
| Sulfuric Acid SCHEMBL10990461 | 0.86 | — | — | |
| Sulfuric Acid SCHEMBL29861157 | 0.84 | — | — | |
| Methylene Chloride SCHEMBL8030727 | 0.82 | — | — | |
| Sulfuric Acid SCHEMBL28663238 | 0.82 | — | — | |
| Sulfuric Acid SCHEMBL10785154 | 0.82 | — | — | |
| Sulfuric Acid SCHEMBL8982176 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112479908-A | Preparation method of salbutamol sulfate impurity D | 江西天戌药业有限公司 | 2021-03-12 | — | — | CN | claimed |
| CN-112479908-B | Preparation method of salbutamol sulfate impurity D | 江西天戌药业有限公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-117447545-A | Synthetic method of deoxycholic acid (DCA) | 上海高准医药有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-112444513-B | Polycyclic aromatic hydrocarbon contaminated soil restoration effect evaluation method and detection kit | 北京建工环境修复股份有限公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-112479908-A | Preparation method of salbutamol sulfate impurity D | 江西天戌药业有限公司 | 2021-03-12 | — | — | CN | disclosed |
| CN-112444513-A | Polycyclic aromatic hydrocarbon contaminated soil remediation effect evaluation method and detection kit | 北京建工环境修复股份有限公司 | 2021-03-05 | — | — | CN | disclosed |
| CN-104245703-B | Cyclic quaternary ammonium salts, nonaqueous solvents, nonaqueous electrolyte and electrical storage device | 株式会社半导体能源研究所 | 2019-02-12 | — | — | CN | disclosed |
| EP-1021185-A4 | DIDHYDROPYRIMIDINES AND USES THEREOF | SYNAPTIC PHARMA CORP (US) | 2005-09-07 | — | — | EP | disclosed |
| US-6245773-B1 | BENIGN PROSTATIC HYPERPLAMIA; REDUCTION OF INTRAOCULAR PRESSURE | SYNAPTIC PHARMACEUTICAL CORPORATION | 2001-06-12 | — | — | US | disclosed |
| EP-1021185-A1 | DIDHYDROPYRIMIDINES AND USES THEREOF | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 2000-07-26 | — | — | EP | disclosed |
| WO-1997042956-A1 | DIDHYDROPYRIMIDINES AND USES THEREOF | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 1997-11-20 | — | — | WO | disclosed |
| EP-0790826-A1 | DIHYDROPYRIMIDINES AND USES THEREOF | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 1997-08-27 | — | — | EP | disclosed |
| WO-1996014846-A1 | DIHYDROPYRIMIDINES AND USES THEREOF | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 1996-05-23 | — | — | WO | disclosed |
| WO-1995033458-A1 | ANTI-INFLAMMATORY COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-12-14 | — | — | WO | disclosed |
| CN-1017337-B | PROCESS FOR PREPARING PHOSPHINIC ACID DERIVATIVES | HOFFMANN LA ROCHE (CH) | 1992-07-08 | — | — | CN | disclosed |
| CN-87101164-A | PHOSPHINIC ACID DERIVATIVES | — | 1988-06-29 | — | — | CN | disclosed |
| US-4472571-A | ANTITUMOR AGNETS; ANTIBIOTICS | HOFFMANN-LA ROCHE INC. (US) | 1984-09-18 | — | — | US | disclosed |
| US-4405713-A | FROM RACEMIC ANTHRACYCLINONE WITH STREPTOMYCES GALILAEUS | HOFFMANN-LA ROCHE INC. (US) | 1983-09-20 | — | — | US | disclosed |
| EP-0083019-A2 | Process for optically active anthracycline glycosides, the novel 4-deoxy-aclacinomycins A and B and pharmaceutical preparations | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1983-07-06 | — | — | EP | disclosed |
| US-4329339-A | Anthracyclinones and derivatives thereof | HOFFMANN-LA ROCHE INC. (US) | 1982-05-11 | — | — | US | disclosed |